Action spectroscopy for new drugs
Date of news: 10 December 2020
Several companies make use of our facilities to advance their research & development. For example, in collaboration with Janssen Research & Development (a division of Janssen Pharmaceutical) we are mapping the effect of small changes in the chemical structure of active substances in new drugs, using mass spectrometry and infrared ion spectroscopy (IRIS), in combination with the unique, tuneable infrared light of the FELIX free electron lasers. Read more on this cooperation in the interview with Head Analytical Sciences Filip Cuyckens in the magazine of the Royal Dutch Chemical Society (Dutch).